Retrospective research from more than a decade ago demonstrated the potential benefit, but it hadn't been confirmed in a ...

In an increasingly crowded space, the firm is using streamlined manufacturing and lipid nanoparticle delivery for its in vivo ...

The firm said it found its antibody-drug conjugate payload had activity as both a monotherapy and in combination with androgen receptor inhibitors.

The approval follows the CHMP's reversal of a previous decision not to recommend the drug, instead recommending it with certain restrictions.

In a new study, Picture Health's QVT score identified responders and non-responders to immunotherapy and chemoimmunotherapy.